HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LK-732

structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        LK-732: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - LK-732: 1

Experts

1.	Bozic, Mojca: 1 article (03/2005)
2.	Budihna, Metka V: 1 article (03/2005)
3.	Cerne, Manica: 1 article (03/2005)
4.	Drevensek, Gorazd: 1 article (03/2005)
5.	Peternel, Luka: 1 article (03/2005)
6.	Stalc, Anton: 1 article (03/2005)
7.	Stegnar, Mojca: 1 article (03/2005)
8.	Urleb, Uros: 1 article (03/2005)
9.	Zega, Anamarija: 1 article (03/2005)

Related Diseases

1.

Thrombosis (Thrombus)

03/01/2005 - "However, in model 2, LK-732 and argatroban decreased thrombus weight by 50% at similar ID50 values (3.8 mg/kg vs 3.0 mg/kg, respectively; p=0.726). "
03/01/2005 - "In model 1, intravenous bolus administration of LK-732 produced a dose-dependent inhibition of thrombus formation with an ID50 value of 1.3 mg/kg. This ID50 value was approximately four times higher than the ID50 value of argatroban (0.3 mg/kg; p=0.011). "

Related Drugs and Biologics

1.	argatroban (MPQA)